Glenmede Trust’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $279K | Sell |
|
|||||
|
2024
Q3 | $292K | Buy |
|
|||||
|
2024
Q2 | $362K | Sell |
|
|||||
|
2024
Q1 | $341K | Buy |
|
|||||
|
2023
Q4 | $232K | Buy |
|
|||||
|
2023
Q3 | $281K | Buy |
|
|||||
|
2023
Q2 | $308K | Hold |
|
|||||
|
2023
Q1 | $308K | Sell |
|
|||||
|
2022
Q4 | $290K | Buy |
|
|||||
|
2022
Q3 | $243K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $343K | Sell |
|
|||||
|
2020
Q3 | $297K | Sell |
|
|||||
|
2020
Q2 | $340K | Buy |
|
|||||
|
2020
Q1 | $272K | Hold |
|
|||||
|
2019
Q4 | $272K | Hold |
|
|||||
|
2019
Q3 | $158 | Sell |
|
|||||
|
2019
Q2 | $320 | Hold |
|
|||||
|
2019
Q1 | $251 | Buy |
|
|||||
|
2018
Q4 | $219 | Buy |
|
|||||
|
2018
Q3 | $323K | Hold |
|
|||||
|
2018
Q2 | $264K | Sell |
|
|||||
|
2018
Q1 | $127K | Hold |
|
|||||
|
2017
Q4 | $127K | Buy |
|
|||||
|
2017
Q3 | $90K | Hold |
|
|||||
|
2017
Q2 | $59K | Hold |
|
|||||
|
2017
Q1 | $59K | Hold |
|
|||||
|
2016
Q4 | $54K | Sell |
|
|||||
|
2016
Q3 | $124K | Buy |
|
|||||
|
2016
Q2 | $38K | Hold |
|
|||||
|
2016
Q1 | $39K | Hold |
|
|||||
|
2015
Q4 | $77K | Hold |
|
|||||
|
2015
Q3 | $64K | Hold |
|
|||||
|
2015
Q2 | $60K | Sell |
|
|||||
|
2015
Q1 | $92K | Hold |
|
|||||
|
2014
Q4 | $101K | Buy |
|
|||||
|
2014
Q3 | $122K | Hold |
|
|||||
|
2014
Q2 | $172K | Hold |
|
|||||
|
2014
Q1 | $139K | Hold |
|
|||||
|
2013
Q4 | $118K | Buy |
|
|||||
|
2013
Q3 | $247K | Buy |
|
|||||
|
2013
Q2 | $190K | Buy |
|